Shares of Hitek Global (HKIT) sank another 8.3% to $0.29 on June 23, extending a punishing slide that has erased nearly 40% of value in just six trading sessions. The China-based IT services micro-cap is caught in a vicious cycle: repeated reverse stock splits designed to keep its Nasdaq listing alive, followed by share sales that flood the market with new stock and crush the price right back down.

  • Two Reverse Splits in Two Months Signal a Listing Emergency. HiTek executed a 1-for-50 reverse split on April 6, 2026, followed by a 1-for-3 reverse split effective May 29 — both aimed at propping the share price above Nasdaq's $1.00 minimum bid requirement. A reverse split reduces the number of shares outstanding to mathematically raise the per-share price, but it creates no new value. The first consolidation drew a -15.83% reaction , and the second has been met with similarly relentless selling. Investors read back-to-back splits as a sign of desperation, not recovery.

  • An $8 Million Offering Massively Diluted Existing Shareholders. Prior to the offering, Hitek Global had just 846,474 Class A ordinary shares outstanding.

After the deal, assuming full warrant exercise, that count ballooned to 19,996,474 — a roughly 24-fold increase in shares. The company sold 4 million shares and 4 million warrants at $2.00 per share , meaning today's $0.29 price sits 85% below the offering price. Buyers who participated are already deep underwater.

  • The Business Can't Support the Stock Drama. Revenue runs around $6.5 million , and market capitalization sits near $3.7 million — vanishingly small by any public-market standard. HKIT shares plummeted 27.39% on June 3 alone , the day the offering closed. Meanwhile, law firm Rosen has issued multiple notices encouraging investors to inquire about a securities class action investigation , adding legal risk to an already grim picture.

  • Broader Crypto and Tech Weakness Adds to the Pain. With Bitcoin down 3.36%, Ethereum off 4.51%, and the Nasdaq sliding 1.71%, speculative micro-caps like HKIT get hit hardest as risk appetite shrinks. HKIT's stock price has declined roughly 99.85% in 2026 , a collapse that no reverse split arithmetic can mask. Until the company can demonstrate revenue growth or a credible path to sustained profitability, every capital-markets maneuver risks accelerating — not arresting — the decline.